EUVIMEDEUVIMED entdecken
Crossref

Amide Proton Transfer‐Weighted Imaging in Assessing the Aggressive and Proliferative Potential of Bladder Cancer

Lingmin Kong, Hui Li, Qian Cai, Wenxin Cao, Yanling Chen, Bei Weng, Meiqin Li, Min Zhang, Long Qian, Yan Guo, Jian Ling, Zhihua Wen und 1 weitere

Journal of Magnetic Resonance Imaging · 2025

DOI: 10.1002/jmri.29464 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Magnetic Resonance Imaging, 2025. Verfasst von Lingmin Kong und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Magnetic Resonance Imaging, Ki-67 Antigen, Protons. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Ki‐67 and human epidermal growth factor receptor 2 (HER2) are known oncogenes involved in bladder cancer (BCa) patient risk stratification. Preoperative assessment of their expression level can assist in clinical treatment decision‐making. Recently, amide proton transfer‐weighted (APTw) MRI has shown promising potential in the diagnosis of several malignancies. However, few studies reported the value of APTw imaging in evaluating Ki‐67 and HER2 status of BCa.

Purpose

To investigate the feasibility of APTw MRI in assessing the aggressive and proliferative potential regarding the expression levels of Ki‐67 and HER2 in BCa. Study Type Retrospective. Subjects 114 patients (mean age, 64.78 ± 11.93 [SD] years; 97 men) were studied. Field Strength/Sequence APTw MRI acquired by a three‐dimensional fast‐spin‐echo sequence at 3.0 T MRI system. Assessment Patient pathologic findings, included histologic grade and the expression status of Ki‐67 and HER2, were reviewed by one uropathologist. The APTw values of BCa were independently measured by two radiologists and were compared between high−/low‐tumor grade group, high−/low‐Ki‐67 expression group, and high−/low‐HER2 expression group. Statistical Tests The interclass correlation coefficient, independent sample t ‐test, Mann–Whitney U test, Spearman's rank correlation, and receiver operating characteristic curve (ROC) analysis were used. P < 0.05 was considered statistically significant.

Results

Significantly higher APTw values were found in high‐grade BCa patients (7.72% vs. 4.29%, P < 0.001), high‐Ki‐67 expression BCa patients (8.40% vs. 3.25%, P < 0.001) and HER2 positive BCa patients (8.24% vs. 5.40%, P = 0.001). APTw values were positively correlated with Ki‐67 ( r = 0.769) and HER2 ( r = 0. 356) expression status. The area under the ROC curve of the APTw values for detecting Ki‐67 and HER2 expression status were 0.883 (95% CI: 0.790–0.945) and 0.713 (95% CI: 0.592–0.816), respectively. Data Conclusions APTw MRI is a potential method to assess the biological and proliferation potential of BCa. Level of Evidence 4. Technical Efficacy Stage 2.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsMagnetic Resonance ImagingKi-67 AntigenProtonsHumansFemaleMaleMiddle AgedRetrospective StudiesAgedErb-b2 Receptor Tyrosine KinasesAmidesCell ProliferationFeasibility StudiesUrinary BladderReproducibility of ResultsAged, 80 and overAdult

Stichwörter der Autor:innen

Amide proton transfer imagingBladder cancerHER2Ki‐67MRI

Substanzen

Ki-67 AntigenProtonsErb-b2 Receptor Tyrosine KinasesAmidesERBB2 protein, human

Autor:innen und Institutionen

  • Department of Radiology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China.
  • Department of Pathology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China.
  • Department of Biomedical Engineering, College of Engineering, Peking University, Beijing, China.

ORCID-Profile: Huanjun Wang

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Kong, L., Li, H., Cai, Q., Cao, W., Chen, Y., Weng, B., Li, M., Zhang, M., Qian, L., Guo, Y., Ling, J., Wen, Z., & Wang, H. (2025). Amide Proton Transfer‐Weighted Imaging in Assessing the Aggressive and Proliferative Potential of Bladder Cancer. Journal of Magnetic Resonance Imaging. https://doi.org/10.1002/jmri.29464

Vancouver

Kong L, Li H, Cai Q, Cao W, Chen Y, Weng B, et al. Amide Proton Transfer‐Weighted Imaging in Assessing the Aggressive and Proliferative Potential of Bladder Cancer. Journal of Magnetic Resonance Imaging. 2025. doi:10.1002/jmri.29464

BibTeX
@article{Kong2025,
  author = {Kong, Lingmin and Li, Hui and Cai, Qian and Cao, Wenxin and Chen, Yanling and Weng, Bei and Li, Meiqin and Zhang, Min and Qian, Long and Guo, Yan and Ling, Jian and Wen, Zhihua and Wang, Huanjun},
  title = {Amide Proton Transfer‐Weighted Imaging in Assessing the Aggressive and Proliferative Potential of Bladder Cancer},
  journal = {Journal of Magnetic Resonance Imaging},
  year = {2025},
  doi = {10.1002/jmri.29464}
}
Kostenlos starten →